[
  {
    "objectID": "NCT04996800",
    "trial_name": "Bezuclastinib in Patients With Advanced Systemic Mastocytosis",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996800",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This research focuses on assessing the outcomes of a targeted therapy drug for individuals diagnosed with early-stage tumors to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT05186701",
    "trial_name": "CGT9486 in Indolent or Smoldering Systemic Mastocytosis",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186701",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The study aims to investigate how a new immunotherapy approach in patients with advanced cancer to improve survival outcomes."
  },
  {
    "objectID": "NCT03800602",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800602",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The study aims to investigate how an advanced biologic therapy among adults suffering from relapsed disease to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT04239003",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239003",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The study aims to investigate how a novel combination of chemotherapy agents in patients with advanced cancer to improve survival outcomes."
  },
  {
    "objectID": "NCT05086604",
    "trial_name": "Beta-only IL-2 ImmunoTherapY Study",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086604",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of an advanced biologic therapy among adults suffering from relapsed disease to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT04996805",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 6",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996805",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This research focuses on assessing the outcomes of a targeted therapy drug among adults suffering from relapsed disease to assess long-term remission rates."
  },
  {
    "objectID": "NCT05186706",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 7",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186706",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This research focuses on assessing the outcomes of a targeted therapy drug in pediatric patients with rare malignancies to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT03800607",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 8",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800607",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of an investigational treatment regimen in patients with advanced cancer to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT04239008",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 9",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239008",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "This clinical trial evaluates the effectiveness of a novel combination of chemotherapy agents for individuals diagnosed with early-stage tumors to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT05086609",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 10",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086609",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of an advanced biologic therapy among adults suffering from relapsed disease to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT04996810",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 11",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996810",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents for individuals diagnosed with early-stage tumors to assess long-term remission rates."
  },
  {
    "objectID": "NCT05186711",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 12",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186711",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a new immunotherapy approach in pediatric patients with rare malignancies to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT03800612",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 13",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800612",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen for those with treatment-resistant cancers to assess long-term remission rates."
  },
  {
    "objectID": "NCT04239013",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 14",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239013",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents in pediatric patients with rare malignancies to assess long-term remission rates."
  },
  {
    "objectID": "NCT05086614",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 15",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086614",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The study aims to investigate how a new immunotherapy approach for individuals diagnosed with early-stage tumors to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT04996815",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 16",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996815",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of an advanced biologic therapy in patients with advanced cancer to assess long-term remission rates."
  },
  {
    "objectID": "NCT05186716",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 17",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186716",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of a targeted therapy drug in patients with advanced cancer to assess long-term remission rates."
  },
  {
    "objectID": "NCT03800617",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 18",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800617",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of an investigational treatment regimen in pediatric patients with rare malignancies to assess long-term remission rates."
  },
  {
    "objectID": "NCT04239018",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 19",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239018",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "This clinical trial evaluates the effectiveness of a targeted therapy drug in patients with advanced cancer to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT05086619",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 20",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086619",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a new immunotherapy approach for those with treatment-resistant cancers to assess long-term remission rates."
  },
  {
    "objectID": "NCT04996820",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 21",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996820",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents in pediatric patients with rare malignancies to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT05186721",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 22",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186721",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents in pediatric patients with rare malignancies to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT03800622",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 23",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800622",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a targeted therapy drug in patients with advanced cancer to assess long-term remission rates."
  },
  {
    "objectID": "NCT04239023",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 24",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239023",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The trial is designed to test the safety and efficacy of a targeted therapy drug for those with treatment-resistant cancers to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT05086624",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 25",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086624",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of an investigational treatment regimen for individuals diagnosed with early-stage tumors to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT04996825",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 26",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996825",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of an investigational treatment regimen for those with treatment-resistant cancers to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT05186726",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 27",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186726",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of a targeted therapy drug among adults suffering from relapsed disease to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT03800627",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 28",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800627",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen for individuals diagnosed with early-stage tumors to assess long-term remission rates."
  },
  {
    "objectID": "NCT04239028",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 29",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239028",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "This research focuses on assessing the outcomes of an advanced biologic therapy in patients with advanced cancer to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT05086629",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 30",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086629",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of an investigational treatment regimen for those with treatment-resistant cancers to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT04996830",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 31",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996830",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen for those with treatment-resistant cancers to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT05186731",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 32",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186731",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen in patients with advanced cancer to improve survival outcomes."
  },
  {
    "objectID": "NCT03800632",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 33",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800632",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen among adults suffering from relapsed disease to improve survival outcomes."
  },
  {
    "objectID": "NCT04239033",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 34",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239033",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "This clinical trial evaluates the effectiveness of a new immunotherapy approach in pediatric patients with rare malignancies to assess long-term remission rates."
  },
  {
    "objectID": "NCT05086634",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 35",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086634",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents for those with treatment-resistant cancers to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT04996835",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 36",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996835",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of an investigational treatment regimen among adults suffering from relapsed disease to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT05186736",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 37",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186736",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of a novel combination of chemotherapy agents for individuals diagnosed with early-stage tumors to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT03800637",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 38",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800637",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a new immunotherapy approach for those with treatment-resistant cancers to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT04239038",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 39",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239038",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The study aims to investigate how an advanced biologic therapy for individuals diagnosed with early-stage tumors to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT05086639",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 40",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086639",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents among adults suffering from relapsed disease to improve survival outcomes."
  },
  {
    "objectID": "NCT04996840",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 41",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996840",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a new immunotherapy approach in pediatric patients with rare malignancies to improve survival outcomes."
  },
  {
    "objectID": "NCT05186741",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 42",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186741",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of an advanced biologic therapy for individuals diagnosed with early-stage tumors to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT03800642",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 43",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800642",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The trial is designed to test the safety and efficacy of a novel combination of chemotherapy agents in patients with advanced cancer to improve survival outcomes."
  },
  {
    "objectID": "NCT04239043",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 44",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239043",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The study aims to investigate how an investigational treatment regimen for individuals diagnosed with early-stage tumors to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT05086644",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 45",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086644",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This research focuses on assessing the outcomes of a targeted therapy drug for individuals diagnosed with early-stage tumors to achieve better tumor shrinkage."
  },
  {
    "objectID": "NCT04996845",
    "trial_name": "(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis - Part 46",
    "cancer_type": [
      "Cancer-Related Syndrome",
      "Leukemia",
      "Myelodysplastic Syndromes (MDS)"
    ],
    "nct_id": "NCT04996845",
    "protocol_ids": ["CGT9486-20-201", "2021-001010-10", "NCI-2021-09477"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a novel combination of chemotherapy agents in pediatric patients with rare malignancies to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT05186746",
    "trial_name": "(Summit) A Study to Evaluate CGT9486 in Indolent or Smoldering Systemic Mastocytosis - Part 47",
    "cancer_type": [
      "Hematopoietic Malignancies",
      "Leukemia",
      "Unknown Primary"
    ],
    "nct_id": "NCT05186746",
    "protocol_ids": ["CGT9486-21-202", "NCI-2022-01167"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "Researchers are exploring the impact of a novel combination of chemotherapy agents in pediatric patients with rare malignancies to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT03800647",
    "trial_name": "6-Hour Oxaliplatin for Nerve Damage in GI Cancer - Part 48",
    "cancer_type": ["Unknown Primary"],
    "nct_id": "NCT03800647",
    "protocol_ids": ["Winship4468-18", "NCI-2018-02241", "IRB00106610"],
    "treatment_sites": [
      {
        "site_name": "Emory Saint Joseph's Hospital",
        "location": "Atlanta"
      },
      {
        "site_name": "Emory University Hospital - Midtown",
        "location": "Atlanta"
      },
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "This clinical trial evaluates the effectiveness of a new immunotherapy approach in pediatric patients with rare malignancies to offer new hope where standard treatments have failed."
  },
  {
    "objectID": "NCT04239048",
    "trial_name": "9-ING-41 in Pediatric Patients With Refractory Malignancies - Part 49",
    "cancer_type": [
      "Brain & Spinal Cord Tumor",
      "Hematopoietic Malignancies",
      "Lymphoma",
      "Neuroblastoma"
    ],
    "nct_id": "NCT04239048",
    "protocol_ids": ["1902", "NCI-2020-04584"],
    "treatment_sites": [],
    "description": "The trial is designed to test the safety and efficacy of an advanced biologic therapy for those with treatment-resistant cancers to reduce treatment-related side effects."
  },
  {
    "objectID": "NCT05086649",
    "trial_name": "A Beta-only IL-2 ImmunoTherapY Study - Part 50",
    "cancer_type": ["Bladder Cancer", "Melanoma", "Stomach/ Gastric Cancer"],
    "nct_id": "NCT05086649",
    "protocol_ids": ["MDNA11-01", "NCI-2022-02678"],
    "treatment_sites": [
      {
        "site_name": "Winship Cancer Institute of Emory University",
        "location": "Atlanta"
      }
    ],
    "description": "The study aims to investigate how an investigational treatment regimen for individuals diagnosed with early-stage tumors to assess long-term remission rates."
  }
]
